ALLIE PUNKE PHARMCOKINETICS. PHENYTOIN THE BASICS What is the volume of distribution: Regular floor patient: 0.6-0.8 L/kg Critically ill patient: 0.8.

Slides:



Advertisements
Similar presentations
Anticonvulsants David G. Standaert, MD, PhD Massachusetts General Hospital Harvard Medical School.
Advertisements

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Principals of fluids and electrolytes management
Clinical Calculation 5th Edition
Advanced Adult Intravenous Calculations
Selected Clinical Calculations
Insulin Administration A patent is admitted to ICU with a diagnosis of DKA. The MD orders a Regular Insulin drip to be infused at 5 units/hour. Review.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/11/12 Enoxaparin Dosing Goal anti-Xa levels are 0.6.
Epilepsy 2 Dr. Hawar A. Mykhan.
Neurological Emergencies Dr. Amal Alkhotani MBBCH, FRCPC, Epilepsy and EEG.
Pharmacokinetics Questions
Introduction to Prescribing - Part 2 3 rd year Medical Students.
Issues Surrounding the Management of Patients Who Present to the ED with Subtherapeutic Phenytoin Levels and a History of Seizures J. Stephen Huff, MD.
Managing and Detecting Seizures in the ICU Special thanks to: Katherine Nickels, MD Assistant Professor of Neurology and Pediatrics Mayo Clinic.
ACEP Clinical Policy: ACEP Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures William C. Dalsey,
23 August 2015 Dr. Bandar Al-Jafen - Neurology Unit - Department of Medicine Management of Status Epilepticus Dr. Bandar Al-Jafen, MD Consultant Neurologist.
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Paediatric Prescribing and Common Medications Diana Mowbray Paediatric Clinical Pharmacist Rotherham NHS Foundation Trust.
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Inpatient Pharmacy Vivian Sinkaset, Pharm.D., BCPS Miramar Science Club Guest Speaker April 28, 2010.
Dosage Regimens II Arthur G. Roberts. Question Can a drug have a low therapeutic index and a broad therapeutic window? No therapeutic index= [drug] min,toxicity.
TREATMENT OF ENDOCRINE EMERGENCIES Sakharova Inna. Ye., M.D, Ph.D.
Inpatient Glycemic Management
PHARMACOKINETICS 1. Fate of drugs in the body 1.1 absorption
Nonlinear Pharmacokinetics
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
Anticonvulsant Pharmacokinetics Dennis Mungall, Pharm.D. Director, Virtual Education, NTPD Associate Professor Pharmacy Practice Ohio State University.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
CLINICAL PHARMACOKINETICS OF LIDOCAINE
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Prof. Dr. Henny Lucida, Apt
Pharmacokinetics of Vancomycin in Adult Oncology Patients Hadeel Al-Kofide MS.c; Iman Zaghloul PhD; and Lamya Al-Naim PharmD Department of Clinical Pharmacy,
Clinical Pharmacokinetics of PHENYTOIN & OTHER ANTIEPILEPTICS
Clinical Pharmacokinetic Equations and Calculations
Case 9 Amikacin in an elderly CKD patient Block 9 : Divine Ramos, Remonte, Reyes, Rivera A, Rivera K, Rivera M, Rogelio, Sagayaga, Santiago, See, Siy,
Theophylline in broncial asthma. By:Heba Othman Essam El-Din Pharm –D4(2009).
Continuous Infusion Vancomycin Pharmacist Education.
Pharmacokinetics 2 General Pharmacology M212
Pharmacokinetics: Digoxin Allie Punke
Pharmacokinetic Questions
Malaria Chemoprophylaxis and treatment By Mohammed Mahmoud, MD.
Quinidine Quinidine  It is used for atrial fibrillation & other arrhythmias. It is given orally as sulfate, gluconate or polygalacturonate salts & in.
ALLIE PUNKE PHARMACOKINETICS: PSYCHOTROPIC DRUGS.
Pharmacokinetics: Warfarin
1 PATIENT SAFETY WORK PRODUCT—Created as part of LPSES - the LMHS Patient Safety Evaluation System Lee Memorial Health System Smart Pump PI Team Smart.
Therapeutics 3 Tutoring Exam 4 February 27 th, 2016 Lisa Hayes
Seizures LMH ER Rounds March 22, 2016 Prepared by Shane Barclay.
Anticonvulsants: Phenytoin
Pharmacokinetics: psychotropic drugs
Allie punke pharmcokinetics Allie punke
Pharmacokinetics: Pediatrics
Pharmacokinetics Tutoring
Pharmacokinetics.
Pharmacokinetics.
Pharmacokinetics: Warfarin
Pharmacokinetics.
Anticonvulsants: Valproic acid
Pharmacokinetics: Pediatrics
Pharmacokinetics: Theophylline
Pharmacokinetics: immunosuppressive drugs
Pharmcokinetics Allie punke.
Pharmcokinetics Allie punke.
Allie Punke Pharmacokinetics Allie Punke
Pharmcokinetics Allie punke.
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Dosage Calculation of Critical Care Medications: mcg/kg/min
Dosage Calculation of Critical Care Medications: mg/min
Presentation transcript:

ALLIE PUNKE PHARMCOKINETICS

PHENYTOIN

THE BASICS What is the volume of distribution: Regular floor patient: L/kg Critically ill patient: 0.8 L/kg What percent is protein bound? 90%, 10% unbound Max rate of infusion of phenytoin? 50 mg/min Max rate of infusion of fosphenytoin? 150 mg PE/min

THE BASICS SE of giving phenytoin too fast? Hypotension & bradycardia…caused by propylene glycol What should phenytoin ONLY be mixed with? NS. Phenytoin or fosphenytoin can be given IM? Fospheynytoin Therapeutic range? Total: Free: 1-2 What is special about the kinetics of phenytoin? Saturable kinetics

THE BASICS You are reviewing medications for a long-term care facility. One of your new patients, NP, is in stable condition and her medication regimen includes phenytoin. How should we avoid the interaction of phenytoin with her enteral feeds? 1. Hold feeds 1-2 hours before/after dosing phenytoin 2. IV phenytoin 3. Bolus feedings & just separate the dosing of phenytoin from feedings.

PHENYTOIN When reviewing labs, you notice that one of your patients in the ICU is on phenytoin with a level of 8. What other information should we look at to interpret this dose? Albumin Timing Overall status of patient Interactions- CYP2C9 Inducers: Rifampin, chronic alcoholic, phenobarbital Inhibition: Cimetidine, omeprazole, fluconazole, amiodarone, isoniazide.

PHENYTOIN HS (100 kg, 69 in) is admitted due to status epilepticus. What LD of phenytoin should we give her? 1. What weight do we use? Adjusted body weight (>130% of IBW) IBW: 66.2 kg ABW: 77.4kg 2. What LD dose (mg/kg) should we use in this patient? LD=20 mg/kg*77.4kg=1550 mg 3. How fast can we give it? 30 minutes (1550 mg 50 mg = xmin 1 minute 4. When/should we draw a level?

PHENYTOIN HS (100 kg, 69 in) is admitted due to status epilepticus. She is on phenytoin at home and has a phenytoin level of 4. What LD should we give her? LD(partial)=(20-4)*0.8L/kg*77.4 kg= 990 mg

PHENYTOIN HS (100 kg, 69 in) is admitted due to status epilepticus. She is on phenytoin at home and has a phenytoin level of 4. Albumin level=2.3. CrCl=57. What LD should we give her? LD(partial)=(20-7)*0.8L/kg*77.4=804 mg Corrected Phenytoin concentration: =7 0.2(2.3)+0.1

PHENYTOIN HS is now stable and is in the ICU for close observation. What should HS’s daily maintenance dose be? 4-8 mg/kg/day 4-6: floor/amb care patients 6-8: critically ill 6 mg/kg*77.4 kg=464 mg

PHENYTOIN In your ambulatory clinic, you adjusted the phenytoin dose appropriately for a patient. When should a level be drawn? A. The next day B. At the end of the dosing interval (>12 hours) C. 2-4 weeks D. 5-7 days

PHENYTOIN A patient with severe renal dysfunction (CrCl<10) has a phenytoin level of 7. Albumin level=2.7. What is her corrected phenytoin concentration? Corrected phenytoin: = (2.7) +0.1

PHENYTOIN A patient is being managed with phenytoin. Because of concern for toxicity (uncoordinated movement, arrhythmias), a level was drawn (phenytoin=32). What should be done? A. Hold the next two doses B. Decrease dose by mg/day and hold for 1-2 days C. Stop phenytoin, get daily levels, and restart when level is <20. D. Continue normal dose, symptoms most likely not due to phenytoin.

QUESTIONS? GOOD LUCK!